Multifunctional Scaffold for Osteoporotic Pathophysiological Microenvironment Improvement and Vascularized Bone Defect Regeneration

Yanan Zhao,Honglei Kang,Xiaopei Wu,Pengzhen Zhuang,Rong Tu,Takashi Goto,Feng Li,Honglian Dai
DOI: https://doi.org/10.1002/adhm.202203099
IF: 10
2023-02-16
Advanced Healthcare Materials
Abstract:Osteoporosis is a degenerative bone disease resulting from bone homeostasis imbalance regulated by osteoblasts and osteoclasts. Treating osteoporotic bone defects tends to be more difficult due to suppressed osteogenic differentiation, hyperactive osteoclastogenesis and impaired angiogenesis. Hence, a drug carrier system composed of gelatin‐coated hollow mesoporous silica nanoparticles (HMSNs/GM) loaded pro‐osteogenic parathyroid (PTH) and anti‐osteoclastogenic alendronate (ALN) is constructed and compounded into calcium magnesium phosphate cements (MCPC). The spatial‐temporal release of ions and drugs, controllable degradation rate, and abundant pore structure of MCPC composites enhance osteoporotic bone regeneration in ovariectomized rats by accelerating vascularization, promoting osteogenic differentiation and mineralization, and inhibiting osteoclastogenesis and bone resorption. The MCPC/HMSNs@ALN‐PTH/GM demonstrates a synergistic threefold effect on osteogenesis, osteoclastogenesis and angiogenesis. It improves the osteoporotic pathophysiological microenvironment and promotes osteoporotic vascularized bone defect regeneration, holding huge potential for other functional biomaterials design and clinical management. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?